ArticleBiomedicines2022

Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience.

Renata Pacholczak-Madej et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.